Targeted Therapy in Nonmelanoma Skin Cancers
Nonmelanoma skin cancer (NMSC) is the most prevalent cancer in light-skinned populations, and includes mainly Basal Cell Carcinomas (BCC), representing around 75% of NMSC and Squamous Cell Carcinomas (SCC). The incidence of these tumors is continuously growing. It was found that the overall number o...
Main Authors: | Giulia Spallone, Elisabetta Botti, Antonio Costanzo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/2/2255/ |
Similar Items
-
Nonmelanoma skin cancers: An Indian perspective
by: Geeti Khullar, et al.
Published: (2014-01-01) -
Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study
by: Cesidio Cipriani, et al.
Published: (2022-02-01) -
Clinicopathological evaluation of nonmelanoma skin cancer
by: Manjula Adinarayan, et al.
Published: (2011-01-01) -
Laser Immunotherapy: A Potential Treatment Modality for Keratinocyte Carcinoma
by: Silje Haukali Omland, et al.
Published: (2021-10-01) -
Early Detection of Skin Disorders and Diseases Using Radiometry
by: Amani Yousef Owda, et al.
Published: (2022-08-01)